Omada Health Analyst Price Targets - Benzinga

Omada Health Inc

OMDANASDAQ

Trade with Public

Trade with Public

$17.91

-0.39-2.16%

Ult. Agg.: Oct 14, 1:52 PM

$18.80

0.502.73%

Panoramica Notizie Previsioni utili EventiObiettivi di prezzoDati finanziari Sentiment Azionariato Confronta Opzioni Rapporto azionario

Omada Health Analyst Price Targets - Benzinga

Omada Health Analyst Price Targets

Wall Street analyst price targets and consensus rating for Omada Health (OMDA).

Price Target Range — 5 Quarters

Analyst Consensus — 12 Analysts

1S.Buy

10Buy

1Hold

Consensus RatingBuy# Analysts12Avg. Consensus PT$27Upside to Avg. PT+48.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 14, 2026	Freedom Capital Markets	Gene Mannheimer	Maintained	Buy	$35
Sep 11, 2026	Barclays	Saket Kalia	PT Raise	Overweight	$25→$27
Sep 11, 2026	Needham	Ryan MacDonald	Maintained	Buy	$28
Sep 11, 2026	BTIG	David Larsen	Maintained	Buy	$35
Aug 14, 2026	JP Morgan	Lisa Gill	PT Raise	Overweight	$26→$30
Aug 14, 2026	Citizens	Constantine Davides	PT Raise	Market Outperform	$27→$32
Aug 12, 2026	Baird	Vikram Kesavabhotla	PT Raise	Neutral	$15→$25
Aug 10, 2026	BTIG	David Larsen	PT Raise	Buy	$30→$35
Aug 3, 2026	Barclays	Saket Kalia	PT Raise	Overweight	$20→$25
Jul 21, 2026	Canaccord Genuity	Richard Close	PT Raise	Buy	$24→$28
Jul 20, 2026	Citizens	Constantine Davides	PT Raise	Market Outperform	$21→$27
Jul 17, 2026	BTIG	David Larsen	Initiate	Buy	$30
Jun 22, 2026	Morgan Stanley	Craig Hettenbach	Maintained	Overweight	$30
May 8, 2026	Barclays	Saket Kalia	PT Raise	Overweight	$18→$20
May 8, 2026	Citizens	Constantine Davides	PT Raise	Market Outperform	$18→$21
May 8, 2026	Evercore ISI Group	Elizabeth Anderson	PT Raise	Outperform	$15→$20
May 8, 2026	Wells Fargo	Stan Berenshteyn	PT Raise	Equal-Weight	$17→$18
May 8, 2026	Needham	Ryan MacDonald	Maintained	Buy	$28
Apr 14, 2026	Citizens	Constantine Davides	Initiate	Market Outperform	$18
Apr 9, 2026	Goldman Sachs	David Roman	PT Cut	Buy	$26→$23

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Barclays Maintains Overweight on Omada Health, Raises Price Target to $27

Barclays analyst Saket Kalia maintains Omada Health (NASDAQ:OMDA) with a Overweight and raises the price target from $25 to $27.

Benzinga Newsdesk

PRO
Needham Reiterates Buy on Omada Health, Maintains $28 Price Target

Needham analyst Ryan MacDonald reiterates Omada Health (NASDAQ:OMDA) with a Buy and maintains $28 price target.

Benzinga Newsdesk

PRO
BTIG Reiterates Buy on Omada Health, Maintains $35 Price Target

BTIG analyst David Larsen reiterates Omada Health (NASDAQ:OMDA) with a Buy and maintains $35 price target.

Benzinga Newsdesk

PRO
JP Morgan Maintains Overweight on Omada Health, Raises Price Target to $30

JP Morgan analyst Lisa Gill maintains Omada Health (NASDAQ:OMDA) with a Overweight and raises the price target from $26 to $30.

Benzinga Newsdesk

PRO
Citizens Maintains Market Outperform on Omada Health, Raises Price Target to $32

Citizens analyst Constantine Davides maintains Omada Health (NASDAQ:OMDA) with a Market Outperform and raises the price target from $27 to $32.

Benzinga Newsdesk

PRO
Baird Maintains Neutral on Omada Health, Raises Price Target to $25

Baird analyst Vikram Kesavabhotla maintains Omada Health (NASDAQ:OMDA) with a Neutral and raises the price target from $15 to $25.

Benzinga Newsdesk